Last reviewed: May 12, 2026
Last updated: May 12, 2026
Written by:
Jay Hastings
,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — evidence-based guidance on GLP-1 therapies, weight management protocols, and the genetic variables behind every metabolic decision. Browse all Peptides & GLP-1 education
Full head-to-head: PlexusDx vs MEDVi →
What follows is an independent editorial review written by the PlexusDx team. We have no commercial relationship with Medvi, hold no affiliate links, and receive no compensation for anything said here.
Search "Medvi Ozempic" and the honest answer is nuanced: Medvi is a GLP-1 telehealth program, but branded Ozempic is not what it dispenses. This review explains what Medvi does prescribe on the semaglutide side, how the compounded route differs from the brand, and the one variable no prescription pad captures. Fair-balance framing, current as of April 2026, not a buying recommendation.
Start a Semaglutide program with PlexusDx
One all-inclusive price covers your online provider visit, prescription, compounded Semaglutide, and shipping — no membership, no hidden fees. Complete a short intake and a licensed provider reviews your fit.
Start your intake →
Does Medvi actually offer Ozempic?
Not the brand. As verified July 2026, Medvi’s weight-management menu centers on compounded semaglutide from licensed 503A pharmacies, not branded Ozempic. Its branded routes — offered separately at a membership plus medication cost — are Wegovy and Zepbound; branded Ozempic sits outside Medvi’s lineup. Confirm the current menu on Medvi’s official website.
Compounded semaglutide versus branded Ozempic
Compounded semaglutide shares the same active ingredient as Ozempic but is a distinct, non-branded preparation produced by a compounding pharmacy rather than the original manufacturer. The molecule is the same class of GLP-1 receptor agonist; the packaging, sourcing, and regulatory pathway differ. That distinction matters when a shopper types a brand name expecting the brand and receives a compounded equivalent instead.
Inside the Medvi prescribing model
The flow is typical of the category: a patient submits an intake covering weight, medical history, and current medications; a licensed clinician reviews it and, if criteria are met, writes a prescription; that script routes to a retail pharmacy for branded products or a 503A pharmacy for compounded semaglutide; and follow-up visits support titration and side-effect management. Provider type and pharmacy partner vary between programs.
What the semaglutide route costs at Medvi
Pricing appears after a short health questionnaire and is promotion-led. As captured July 2026, compounded semaglutide runs about $299 per month ongoing, flat across dose, with multi-month prepaid bundles available. The compounded program carries no membership fee; branded Wegovy or Zepbound options add a $99 membership plus medication cost. A dissolvable GLP-1 tablet is also listed, priced after intake. Numbers change often — verify before committing.
The Ozempic clinical record
Any legitimate semaglutide program rests on the same evidence base. Semaglutide is a GLP-1 receptor agonist, alongside liraglutide and dulaglutide, while tirzepatide is a GIP/GLP-1 dual agonist. The STEP program (semaglutide for weight management, The New England Journal of Medicine, 2021) anchors the weight-loss data; SURMOUNT (tirzepatide, NEJM 2022) and SURMOUNT-OSA (NEJM 2024) extend the dual-agonist record. Trial populations and endpoints differ, and individual outcomes vary.
The genetic layer an Ozempic prescription skips
No telehealth script — branded or compounded — reads the metabolic terrain it prescribes into. Variants in GLP1R, the gene encoding the GLP-1 receptor that semaglutide targets, along with FTO, MC4R, and TCF7L2, describe your baseline appetite, energy-balance, and glucose-handling biology. These are pathway-level insights: they do not predict response to any specific compound, but they frame the conversation. PlexusDx offers semaglutide and tirzepatide through its Weight Management Protocols — Semaglutide Injection, Semaglutide Oral, Tirzepatide Injection, and Tirzepatide Oral — and pairs them with the Precision Peptide Genetic Test, which analyzes 14 pathways, 49 peptides, 150+ genetic insights. That is the test before you invest approach.
Not affiliated: PlexusDx has no relationship with Medvi and no commercial tie to the companies named in this article.
Related reading on PlexusDx: Ozempic Near Me, Ozempic Cost Without Insurance, Cost Of Ozempic Per Month, Cost Of Ozempic.
Disclaimer: This article is educational. PlexusDx is not affiliated with Medvi and has no commercial relationship with the companies reviewed. PlexusDx offers semaglutide and tirzepatide through its own Weight Management Protocols; this review compares approaches in the GLP-1 telehealth space. The Precision Peptide Genetic Test analyzes how your genes influence peptide-related pathways — it does not predict response to any specific medication. Consult a qualified healthcare provider before beginning any peptide protocol.
Compare approaches: see the Weight Management Protocols, or start upstream and take the Precision Peptide Genetic Test to understand your GLP-1 pathway first.
Frequently Asked Questions
Does Medvi prescribe brand-name Ozempic?
As verified July 2026, branded Ozempic is not on Medvi’s menu. Its weight-management program centers on compounded semaglutide from 503A pharmacies, with branded Wegovy and Zepbound offered separately under a membership. Anyone specifically seeking brand-name Ozempic should confirm availability directly on Medvi’s site.
Is compounded semaglutide the same as Ozempic?
It uses the same active ingredient, semaglutide, but is a distinct non-branded preparation made by a compounding pharmacy rather than the original manufacturer. The GLP-1 mechanism is shared; the sourcing, packaging, and regulatory pathway differ. Compounded products are not FDA-approved brand equivalents, so review the distinction carefully.
How much does Medvi’s semaglutide route cost?
Captured July 2026, compounded semaglutide is about $299 per month ongoing, flat across dose, with prepaid multi-month bundles available. The compounded plan has no membership fee. Pricing displays after a health questionnaire and changes frequently, so verify current figures.
How does the Precision Peptide Genetic Test fit an Ozempic decision?
It does not predict how you will respond to Ozempic or any compound. It maps pathway-level variants in FTO and MC4R, and TCF7L2 that shape your baseline GLP-1 biology — upstream context that applies no matter which service or compound a clinician ultimately prescribes.
This article is part of the PlexusDx Education Hub. Browse all Peptides & GLP-1 education
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Medvi vs Direct Meds: Medication Options and Eligibility Compared
Medvi Peptides: What the GLP-1 Program Actually Offers